Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals.

Journal of clinical epidemiology

van Walraven C, McAlister FA.
PMID: 26232083
J Clin Epidemiol. 2016 Jan;69:170-3.e8. doi: 10.1016/j.jclinepi.2015.07.006. Epub 2015 Jul 29.

OBJECTIVE: Risk estimates from Kaplan-Meier curves are well known to medical researchers, reviewers, and editors. In this study, we determined the proportion of Kaplan-Meier analyses published in prominent medical journals that are potentially biased because of competing events ("competing...

Cite
van Walraven C, McAlister FA. Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals. J Clin Epidemiol. 2015;69:170-3.e8doi: 10.1016/j.jclinepi.2015.07.006.
van Walraven, C., & McAlister, F. A. (2016). Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals. Journal of clinical epidemiology, 69170-3.e8. https://doi.org/10.1016/j.jclinepi.2015.07.006
van Walraven, Carl, and McAlister, Finlay A. "Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals." Journal of clinical epidemiology vol. 69 (2016): 170-3.e8. doi: https://doi.org/10.1016/j.jclinepi.2015.07.006
van Walraven C, McAlister FA. Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals. J Clin Epidemiol. 2016 Jan;69:170-3.e8. doi: 10.1016/j.jclinepi.2015.07.006. Epub 2015 Jul 29. PMID: 26232083.
Copy Download .nbib Format: NLM
Impact of mental health problems on case fatality in male cancer patients.

British journal of cancer

Batty GD, Whitley E, Gale CR, Osborn D, Tynelius P, Rasmussen F.
PMID: 22516950
Br J Cancer. 2012 May 22;106(11):1842-5. doi: 10.1038/bjc.2012.150. Epub 2012 Apr 19.

BACKGROUND: Although mortality rates are elevated in psychiatric patients relative to their healthy counterparts, little is known about the impact of mental health on survival in people with cancer.METHODS AND RESULTS: Among 16 498 Swedish men with cancer, survival...

Cite
Batty GD, Whitley E, Gale CR, et al. Impact of mental health problems on case fatality in male cancer patients. Br J Cancer. 2012;106(11):1842-5doi: 10.1038/bjc.2012.150.
Batty, G. D., Whitley, E., Gale, C. R., Osborn, D., Tynelius, P., & Rasmussen, F. (2012). Impact of mental health problems on case fatality in male cancer patients. British journal of cancer, 106(11), 1842-5. https://doi.org/10.1038/bjc.2012.150
Batty, G D, et al. "Impact of mental health problems on case fatality in male cancer patients." British journal of cancer vol. 106,11 (2012): 1842-5. doi: https://doi.org/10.1038/bjc.2012.150
Batty GD, Whitley E, Gale CR, Osborn D, Tynelius P, Rasmussen F. Impact of mental health problems on case fatality in male cancer patients. Br J Cancer. 2012 May 22;106(11):1842-5. doi: 10.1038/bjc.2012.150. Epub 2012 Apr 19. PMID: 22516950; PMCID: PMC3364129.
Copy Download .nbib Format: NLM
Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.

Journal of biopharmaceutical statistics

Wang X, Bai F, Pang H, George SL.
PMID: 31286838
J Biopharm Stat. 2019;29(4):592-605. doi: 10.1080/10543406.2019.1633659. Epub 2019 Jul 09.

For time-to-event outcomes, the Kaplan-Meier estimator is commonly used to estimate survival functions of treatment groups and to compute marginal treatment effects, such as the difference in survival rates between treatments at a landmark time. The derived estimates of...

Cite
Wang X, Bai F, Pang H, et al. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies. J Biopharm Stat. 2019;29(4):592-605doi: 10.1080/10543406.2019.1633659.
Wang, X., Bai, F., Pang, H., & George, S. L. (2019). Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies. Journal of biopharmaceutical statistics, 29(4), 592-605. https://doi.org/10.1080/10543406.2019.1633659
Wang, Xiaofei, et al. "Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies." Journal of biopharmaceutical statistics vol. 29,4 (2019): 592-605. doi: https://doi.org/10.1080/10543406.2019.1633659
Wang X, Bai F, Pang H, George SL. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies. J Biopharm Stat. 2019;29(4):592-605. doi: 10.1080/10543406.2019.1633659. Epub 2019 Jul 09. PMID: 31286838; PMCID: PMC6684083.
Copy Download .nbib Format: NLM
Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry.

Journal of the National Cancer Institute

Slavin TP, Van Tongeren LR, Behrendt CE, Solomon I, Rybak C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Tao S, Yang K, Culver JO, Sand S, Castillo D, Herzog J, Gray SW, Weitzel JN.
PMID: 29618041
J Natl Cancer Inst. 2018 Oct 01;110(10):1059-1066. doi: 10.1093/jnci/djy027.

BACKGROUND: In germline genetic testing, variants from understudied ancestries have been disproportionately classified as being of uncertain significance. We hypothesized that the rate of variant reclassification likewise differs by ancestry.METHODS: Nonbenign variants in actionable genes were collected from consenting...

Cite
Slavin TP, Van Tongeren LR, Behrendt CE, et al. Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. J Natl Cancer Inst. 2018;110(10):1059-1066doi: 10.1093/jnci/djy027.
Slavin, T. P., Van Tongeren, L. R., Behrendt, C. E., Solomon, I., Rybak, C., Nehoray, B., Kuzmich, L., Niell-Swiller, M., Blazer, K. R., Tao, S., Yang, K., Culver, J. O., Sand, S., Castillo, D., Herzog, J., Gray, S. W., & Weitzel, J. N. (2018). Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. Journal of the National Cancer Institute, 110(10), 1059-1066. https://doi.org/10.1093/jnci/djy027
Slavin, Thomas P, et al. "Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry." Journal of the National Cancer Institute vol. 110,10 (2018): 1059-1066. doi: https://doi.org/10.1093/jnci/djy027
Slavin TP, Van Tongeren LR, Behrendt CE, Solomon I, Rybak C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Tao S, Yang K, Culver JO, Sand S, Castillo D, Herzog J, Gray SW, Weitzel JN. Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. J Natl Cancer Inst. 2018 Oct 01;110(10):1059-1066. doi: 10.1093/jnci/djy027. PMID: 29618041; PMCID: PMC6249694.
Copy Download .nbib Format: NLM
Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer.

Anticancer research

Janssen S, VAN Oorschot B, Käsmann L, Schild SE, Rades D.
PMID: 28476824
Anticancer Res. 2017 May;37(5):2537-2540. doi: 10.21873/anticanres.11596.

AIM: To validate a score estimating the 6-month survival of lung cancer patients irradiated for locally advanced disease.PATIENTS AND METHODS: The validation cohort of this study included 125 patients. The score for each patient was calculated by adding the...

Cite
Janssen S, VAN Oorschot B, Käsmann L, et al. Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer Res. 2017;37(5):2537-2540doi: 10.21873/anticanres.11596.
Janssen, S., VAN Oorschot, B., Käsmann, L., Schild, S. E., & Rades, D. (2017). Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer research, 37(5), 2537-2540. https://doi.org/10.21873/anticanres.11596
Janssen, Stefan, et al. "Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer." Anticancer research vol. 37,5 (2017): 2537-2540. doi: https://doi.org/10.21873/anticanres.11596
Janssen S, VAN Oorschot B, Käsmann L, Schild SE, Rades D. Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer Res. 2017 May;37(5):2537-2540. doi: 10.21873/anticanres.11596. PMID: 28476824.
Copy Download .nbib Format: NLM
Aspiration in the otherwise healthy Infant-Is there a natural course for improvement?.

The Laryngoscope

Casazza GC, Graham ME, Asfour F, O'Gorman M, Skirko J, Meier JD.
PMID: 30835858
Laryngoscope. 2020 Feb;130(2):514-520. doi: 10.1002/lary.27888. Epub 2019 Mar 05.

OBJECTIVES/HYPOTHESIS: Timing and indication for surgical intervention is a major challenge in managing pediatric oropharyngeal dysphagia. No study has evaluated a natural course of swallowing dysfunction in otherwise healthy infants. Our objective was to review the outcomes and time...

Cite
Casazza GC, Graham ME, Asfour F, et al. Aspiration in the otherwise healthy Infant-Is there a natural course for improvement?. Laryngoscope. 2019;130(2):514-520doi: 10.1002/lary.27888.
Casazza, G. C., Graham, M. E., Asfour, F., O'Gorman, M., Skirko, J., & Meier, J. D. (2020). Aspiration in the otherwise healthy Infant-Is there a natural course for improvement?. The Laryngoscope, 130(2), 514-520. https://doi.org/10.1002/lary.27888
Casazza, Geoffrey C, et al. "Aspiration in the otherwise healthy Infant-Is there a natural course for improvement?." The Laryngoscope vol. 130,2 (2020): 514-520. doi: https://doi.org/10.1002/lary.27888
Casazza GC, Graham ME, Asfour F, O'Gorman M, Skirko J, Meier JD. Aspiration in the otherwise healthy Infant-Is there a natural course for improvement?. Laryngoscope. 2020 Feb;130(2):514-520. doi: 10.1002/lary.27888. Epub 2019 Mar 05. PMID: 30835858.
Copy Download .nbib Format: NLM
We need better figures! In regard to Lee.

International journal of radiation oncology, biology, physics

Bauman G.
PMID: 24661674
Int J Radiat Oncol Biol Phys. 2014 Apr 01;88(5):1212-3. doi: 10.1016/j.ijrobp.2014.01.003.

No abstract available.

Cite
Bauman G. We need better figures! In regard to Lee. Int J Radiat Oncol Biol Phys. 2014;88(5):1212-3doi: 10.1016/j.ijrobp.2014.01.003.
Bauman, G. (2014). We need better figures! In regard to Lee. International journal of radiation oncology, biology, physics, 88(5), 1212-3. https://doi.org/10.1016/j.ijrobp.2014.01.003
Bauman, Glenn. "We need better figures! In regard to Lee." International journal of radiation oncology, biology, physics vol. 88,5 (2014): 1212-3. doi: https://doi.org/10.1016/j.ijrobp.2014.01.003
Bauman G. We need better figures! In regard to Lee. Int J Radiat Oncol Biol Phys. 2014 Apr 01;88(5):1212-3. doi: 10.1016/j.ijrobp.2014.01.003. PMID: 24661674.
Copy Download .nbib Format: NLM
In reply to Bauman.

International journal of radiation oncology, biology, physics

Zietman AL.
PMID: 24661676
Int J Radiat Oncol Biol Phys. 2014 Apr 01;88(5):1213. doi: 10.1016/j.ijrobp.2014.01.004.

No abstract available.

Cite
Zietman AL. In reply to Bauman. Int J Radiat Oncol Biol Phys. 2014;88(5):1213doi: 10.1016/j.ijrobp.2014.01.004.
Zietman, A. L. (2014). In reply to Bauman. International journal of radiation oncology, biology, physics, 88(5), 1213. https://doi.org/10.1016/j.ijrobp.2014.01.004
Zietman, Anthony L. "In reply to Bauman." International journal of radiation oncology, biology, physics vol. 88,5 (2014): 1213. doi: https://doi.org/10.1016/j.ijrobp.2014.01.004
Zietman AL. In reply to Bauman. Int J Radiat Oncol Biol Phys. 2014 Apr 01;88(5):1213. doi: 10.1016/j.ijrobp.2014.01.004. PMID: 24661676.
Copy Download .nbib Format: NLM
Holiday reading: The Mayan Doomsday's effect on survival outcomes in clinical trials.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Wheatley-Price P, Hutton B, Clemons M.
PMID: 23230049
CMAJ. 2012 Dec 11;184(18):2021-2. doi: 10.1503/cmaj.121616.

No abstract available.

Cite
Wheatley-Price P, Hutton B, Clemons M. Holiday reading: The Mayan Doomsday's effect on survival outcomes in clinical trials. CMAJ. 2012;184(18):2021-2doi: 10.1503/cmaj.121616.
Wheatley-Price, P., Hutton, B., & Clemons, M. (2012). Holiday reading: The Mayan Doomsday's effect on survival outcomes in clinical trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 184(18), 2021-2. https://doi.org/10.1503/cmaj.121616
Wheatley-Price, Paul, et al. "Holiday reading: The Mayan Doomsday's effect on survival outcomes in clinical trials." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 184,18 (2012): 2021-2. doi: https://doi.org/10.1503/cmaj.121616
Wheatley-Price P, Hutton B, Clemons M. Holiday reading: The Mayan Doomsday's effect on survival outcomes in clinical trials. CMAJ. 2012 Dec 11;184(18):2021-2. doi: 10.1503/cmaj.121616. PMID: 23230049; PMCID: PMC3519189.
Copy Download .nbib Format: NLM
geneSurv: An interactive web-based tool for survival analysis in genomics research.

Computers in biology and medicine

Korkmaz S, Goksuluk D, Zararsiz G, Karahan S.
PMID: 28889076
Comput Biol Med. 2017 Oct 01;89:487-496. doi: 10.1016/j.compbiomed.2017.08.031. Epub 2017 Sep 05.

Survival analysis methods are often used in cancer studies. It has been shown that the combination of clinical data with genomics increases the predictive performance of survival analysis methods. But, this leads to a high-dimensional data problem. Fortunately, new...

Cite
Korkmaz S, Goksuluk D, Zararsiz G, et al. geneSurv: An interactive web-based tool for survival analysis in genomics research. Comput Biol Med. 2017;89:487-496doi: 10.1016/j.compbiomed.2017.08.031.
Korkmaz, S., Goksuluk, D., Zararsiz, G., & Karahan, S. (2017). geneSurv: An interactive web-based tool for survival analysis in genomics research. Computers in biology and medicine, 89487-496. https://doi.org/10.1016/j.compbiomed.2017.08.031
Korkmaz, Selcuk, et al. "geneSurv: An interactive web-based tool for survival analysis in genomics research." Computers in biology and medicine vol. 89 (2017): 487-496. doi: https://doi.org/10.1016/j.compbiomed.2017.08.031
Korkmaz S, Goksuluk D, Zararsiz G, Karahan S. geneSurv: An interactive web-based tool for survival analysis in genomics research. Comput Biol Med. 2017 Oct 01;89:487-496. doi: 10.1016/j.compbiomed.2017.08.031. Epub 2017 Sep 05. PMID: 28889076.
Copy Download .nbib Format: NLM
Colorectal carcinoma in the first decade of life: a systematic review.

International journal of colorectal disease

da Costa Vieira RA, Tramonte MS, Lopes LF.
PMID: 25916603
Int J Colorectal Dis. 2015 Aug;30(8):1001-6. doi: 10.1007/s00384-015-2202-1. Epub 2015 Apr 28.

PURPOSE: The aim of this study is to better understand the main aspects related to colorectal carcinoma diagnosed in the first 10 years of life, through a systematic review.METHODS: We carried out a bibliographic search in PubMed and LILACS,...

Cite
da Costa Vieira RA, Tramonte MS, Lopes LF. Colorectal carcinoma in the first decade of life: a systematic review. Int J Colorectal Dis. 2015;30(8):1001-6doi: 10.1007/s00384-015-2202-1.
da Costa Vieira, R. A., Tramonte, M. S., & Lopes, L. F. (2015). Colorectal carcinoma in the first decade of life: a systematic review. International journal of colorectal disease, 30(8), 1001-6. https://doi.org/10.1007/s00384-015-2202-1
da Costa Vieira, René Aloisio, et al. "Colorectal carcinoma in the first decade of life: a systematic review." International journal of colorectal disease vol. 30,8 (2015): 1001-6. doi: https://doi.org/10.1007/s00384-015-2202-1
da Costa Vieira RA, Tramonte MS, Lopes LF. Colorectal carcinoma in the first decade of life: a systematic review. Int J Colorectal Dis. 2015 Aug;30(8):1001-6. doi: 10.1007/s00384-015-2202-1. Epub 2015 Apr 28. PMID: 25916603.
Copy Download .nbib Format: NLM
Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?.

Journal of child neurology

Soim A, Smith MG, Kwon JM, Mann JR, Thomas S, Ciafaloni E.
PMID: 29759004
J Child Neurol. 2018 Jul;33(8):537-545. doi: 10.1177/0883073818773029. Epub 2018 May 15.

The objective of this study was to investigate whether males who were born preterm took longer to receive a Duchenne muscular dystrophy diagnosis than term males. Data for males with Duchenne muscular dystrophy identified through a population-based surveillance system...

Cite
Soim A, Smith MG, Kwon JM, et al. Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?. J Child Neurol. 2018;33(8):537-545doi: 10.1177/0883073818773029.
Soim, A., Smith, M. G., Kwon, J. M., Mann, J. R., Thomas, S., Ciafaloni, E. (2018). Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?. Journal of child neurology, 33(8), 537-545. https://doi.org/10.1177/0883073818773029
Soim, Aida, et al. "Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?." Journal of child neurology vol. 33,8 (2018): 537-545. doi: https://doi.org/10.1177/0883073818773029
Soim A, Smith MG, Kwon JM, Mann JR, Thomas S, Ciafaloni E. Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?. J Child Neurol. 2018 Jul;33(8):537-545. doi: 10.1177/0883073818773029. Epub 2018 May 15. PMID: 29759004; PMCID: PMC5995644.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries